$REE
REE Automotive Ltd. Stock $ree

$ree Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000184358823000010 Filed on March 28, 2023

Income Statement

Concept	2022 Q4	2022	2021 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cost Of Revenue	$0.00	$547.0K	$656.0K
YoY Change	-100.0%	-45.03%	1.39%
Gross Profit	$0.00	-$547.0K	-$656.0K
YoY Change	-100.0%	-44.69%	153.28%
Gross Profit Margin
Selling, General & Admin	$9.388M	$49.20M	$15.54M
YoY Change	-39.58%	-81.23%	-59.38%
% of Gross Profit
Research & Development	$18.42M	$78.23M	$23.29M
YoY Change	-20.9%	-69.01%
% of Gross Profit
Depreciation & Amortization	-$1.141M	$1.683M	$192.0K
YoY Change	-694.27%	247.73%	15.66%
% of Gross Profit
Operating Expenses	$27.81M	$127.4M	$38.83M
YoY Change	-28.38%	-75.23%	-42.76%
Operating Profit	-$27.81M	-$128.0M	-$39.49M
YoY Change	-29.57%	-75.17%	-42.02%
Interest Expense	$633.0K	$4.371M	$297.0K
YoY Change	113.13%	926.06%	-22.86%
% of Operating Profit
Other Income/Expense, Net	$0.00	$4.371M	-$6.239M
YoY Change	-100.0%	-60.34%
Pretax Income	-$27.18M	-$105.7M	-$45.43M
YoY Change	-40.17%	-79.04%	-32.91%
Income Tax	$81.00K	$1.748M	$1.223M
% Of Pretax Income
Net Earnings	-$27.26M	-$107.4M	-$46.65M
YoY Change	-41.57%	-78.74%	-31.1%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.09	-$0.37	-$141.1K
COMMON SHARES
Basic Shares Outstanding		293.5M shares
Diluted Shares Outstanding		293.5M shares

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$153.6M	$153.6M	$275.8M
YoY Change	-44.29%	-44.29%	18755.3%
Cash & Equivalents	$56.76M	$56.76M	$275.8M
Short-Term Investments	$96.86M	$96.86M	$0.00
Other Short-Term Assets	$7.472M	$7.472M	$6.186M
YoY Change	20.79%	20.79%	22701.33%
Inventory	$0.00		$0.00
Prepaid Expenses	$5.008M		$5.151M
Receivables	$0.00		$0.00
Other Receivables	$434.0K		$6.114M
Total Short-Term Assets	$165.7M	$165.7M	$288.1M
YoY Change	-42.49%	-42.49%	19237.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$16.94M	$43.00M	$2.675M
YoY Change	533.23%	1507.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.001M	$3.001M	$1.005M
YoY Change	198.61%	198.61%
Total Long-Term Assets	$49.34M	$49.34M	$4.864M
YoY Change	914.35%	914.35%	-97.58%
TOTAL ASSETS
Total Short-Term Assets	$165.7M	$165.7M	$288.1M
Total Long-Term Assets	$49.34M	$49.34M	$4.864M
Total Assets	$215.0M	$215.0M	$292.9M
YoY Change	-26.6%	-26.6%	44.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.172M	$6.172M	$4.538M
YoY Change	36.01%	36.01%	3491.04%
Accrued Expenses	$8.731M	$8.731M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$20.04M	$20.04M	$20.56M
YoY Change	-2.52%	-2.52%	-46.14%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$19.57M	$19.57M	$21.98M
YoY Change	-10.97%	-10.97%
Total Long-Term Liabilities	$19.57M	$19.57M	$21.98M
YoY Change	-10.97%	-10.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.04M	$20.04M	$20.56M
Total Long-Term Liabilities	$19.57M	$19.57M	$21.98M
Total Liabilities	$39.60M	$39.60M	$42.53M
YoY Change	-6.89%	-6.89%	11.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$721.9M		-$614.5M
YoY Change	17.48%
Common Stock	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$175.4M	$175.4M	$250.4M
YoY Change
Total Liabilities & Shareholders Equity	$215.0M	$215.0M	$292.9M
YoY Change	-26.6%	-26.6%	44.49%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income	-$27.26M	-$107.4M	-$46.65M
YoY Change	-41.57%	-78.74%	-31.1%
Depreciation, Depletion And Amortization	-$1.141M	$1.683M	$192.0K
YoY Change	-694.27%	247.73%	15.66%
Cash From Operating Activities	-$27.77M	-$112.6M	-$18.47M
YoY Change	50.34%	90.37%	41.4%
INVESTING ACTIVITIES
Capital Expenditures	$2.037M	$11.06M	-$987.0K
YoY Change	-306.38%	-557.89%	65.88%
Acquisitions
YoY Change
Other Investing Activities	$21.00M	-$95.78M	$0.00
YoY Change		-5845.47%	-100.0%
Cash From Investing Activities	$18.96M	-$106.8M	-$987.0K
YoY Change	-2021.18%	14182.75%	-56.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$809.0K
YoY Change			-97.56%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	85.00K	$2.430M	809.0K
YoY Change	-89.49%	-99.17%	-97.56%
NET CHANGE
Cash From Operating Activities	-27.77M	-$112.6M	-18.47M
Cash From Investing Activities	18.96M	-$106.8M	-987.0K
Cash From Financing Activities	85.00K	$2.430M	809.0K
Net Change In Cash	-8.721M	-$217.0M	-18.65M
YoY Change	-53.23%	-193.77%	-204.79%
FREE CASH FLOW
Cash From Operating Activities	-$27.77M	-$112.6M	-$18.47M
Capital Expenditures	$2.037M	$11.06M	-$987.0K
Free Cash Flow	-$29.81M	-$123.6M	-$17.48M
YoY Change	70.48%	117.97%	40.23%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001843588
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#FairValueAdjustmentOfWarrants
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Auditor Firm AuditorFirmId	1281
CY2022	dei	Auditor Name AuditorName	KOST FORER GABBAY & KASIERER
CY2022	dei	Auditor Location AuditorLocation	Tel-Aviv, Israel
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56762000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	275772000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	162000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	138000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	96857000	usd
CY2021Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	0	usd
CY2022Q4	ree	Prepaid Expense And Other Accounts Receivable Current PrepaidExpenseAndOtherAccountsReceivableCurrent	11894000	usd
CY2021Q4	ree	Prepaid Expense And Other Accounts Receivable Current PrepaidExpenseAndOtherAccountsReceivableCurrent	12162000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	165675000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	288072000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	3001000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1005000	usd
CY2022Q4	us-gaap	Accounts Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent AccountsReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent	3337000	usd
CY2021Q4	us-gaap	Accounts Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent AccountsReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent	1184000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26061000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16939000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2675000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	49338000	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	4864000	usd
CY2022Q4	us-gaap	Assets Assets	215013000	usd
CY2021Q4	us-gaap	Assets Assets	292936000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	6172000	usd
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	4538000	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	11118000	usd
CY2021Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	16018000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2748000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20038000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20556000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	943000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	943000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	21034000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	18623000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	19566000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	21977000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	39604000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	42533000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	ree	Common And Preferred Stock Value Issued CommonAndPreferredStockValueIssued	0	usd
CY2021Q4	ree	Common And Preferred Stock Value Issued CommonAndPreferredStockValueIssued	0	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	897337000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	864911000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-721928000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-614508000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	175409000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	250403000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	215013000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	292936000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	388000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	547000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	995000	usd
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	647000	usd
CY2022	us-gaap	Gross Profit GrossProfit	-547000	usd
CY2021	us-gaap	Gross Profit GrossProfit	-989000	usd
CY2020	us-gaap	Gross Profit GrossProfit	-259000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	78225000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	252424000	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	29589000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	49200000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	262083000	usd
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	38250000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	127425000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	514507000	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	67839000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-127972000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-515496000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-68098000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-17929000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-11024000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4371000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	423000	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	385000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-105672000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-504049000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-67713000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1748000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1281000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-107420000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-505330000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-67713000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-107420000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-505330000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-67713000	usd
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	293499025	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	293499025	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	235612764	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	235612764	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	155930380	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	155930380	shares
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	26.7017
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	27612000	usd
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25825000	usd
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	209000	usd
CY2020	ree	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	7085000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	52763000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-67713000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	45781000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	809000	usd
CY2021	ree	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	2907000	usd
CY2021	ree	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	258159000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	448077000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-505330000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	250403000	usd
CY2022	ree	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	2430000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3104000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	26892000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-107420000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	175409000	usd
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	26.7017
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-107420000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-505330000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-67713000	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1683000	usd
CY2021	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	484000	usd
CY2020	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	166000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	3226000	usd
CY2022	ree	Accretion Income On Held To Maturity Securities AccretionIncomeOnHeldToMaturitySecurities	654000	usd
CY2021	ree	Accretion Income On Held To Maturity Securities AccretionIncomeOnHeldToMaturitySecurities	0	usd
CY2020	ree	Accretion Income On Held To Maturity Securities AccretionIncomeOnHeldToMaturitySecurities	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	26892000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	448077000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	52763000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-17929000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-11024000	usd
CY2022	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	0	usd
CY2021	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	2887000	usd
CY2020	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	0	usd
CY2022	ree	Increase Decrease In Accrued Interest Held To Maturity Securities IncreaseDecreaseInAccruedInterestHeldToMaturitySecurities	425000	usd
CY2021	ree	Increase Decrease In Accrued Interest Held To Maturity Securities IncreaseDecreaseInAccruedInterestHeldToMaturitySecurities	0	usd
CY2020	ree	Increase Decrease In Accrued Interest Held To Maturity Securities IncreaseDecreaseInAccruedInterestHeldToMaturitySecurities	0	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-271000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-107000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-55000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4055000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	12859000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	137000	usd
CY2022	ree	Increase Decrease In Operating Lease Right Of Use Asset And Liability Net IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiabilityNet	7916000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	943000	usd
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-10000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1106000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	3782000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	368000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-4900000	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	13450000	usd
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1396000	usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	19000	usd
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	125000	usd
CY2020	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	18000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-112585000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-59139000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13062000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11058000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2415000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	595000	usd
CY2022	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	139891000	usd
CY2021	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	usd
CY2020	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	44114000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	usd
CY2020	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	usd
CY2022	us-gaap	Proceeds From Payments For In Interest Bearing Deposits In Banks ProceedsFromPaymentsForInInterestBearingDepositsInBanks	0	usd
CY2021	us-gaap	Proceeds From Payments For In Interest Bearing Deposits In Banks ProceedsFromPaymentsForInInterestBearingDepositsInBanks	1667000	usd
CY2020	us-gaap	Proceeds From Payments For In Interest Bearing Deposits In Banks ProceedsFromPaymentsForInInterestBearingDepositsInBanks	-1667000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-106835000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-748000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2262000	usd
CY2022	ree	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	2430000	usd
CY2021	ree	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	809000	usd
CY2020	ree	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	209000	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	25825000	usd
CY2022	ree	Proceeds From Warrant Exercises To Preferred Stock ProceedsFromWarrantExercisesToPreferredStock	0	usd
CY2021	ree	Proceeds From Warrant Exercises To Preferred Stock ProceedsFromWarrantExercisesToPreferredStock	2907000	usd
CY2020	ree	Proceeds From Warrant Exercises To Preferred Stock ProceedsFromWarrantExercisesToPreferredStock	7085000	usd
CY2022	ree	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	0	usd
CY2021	ree	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	287579000	usd
CY2020	ree	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2430000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	291295000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33119000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-216990000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	231408000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17795000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	276915000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45507000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27712000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59925000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	276915000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45507000	usd
CY2022	ree	Noncash Deferred Acquisition Costs NoncashDeferredAcquisitionCosts	0	usd
CY2021	ree	Noncash Deferred Acquisition Costs NoncashDeferredAcquisitionCosts	0	usd
CY2020	ree	Noncash Deferred Acquisition Costs NoncashDeferredAcquisitionCosts	328000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2739000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	114000	usd
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	61000	usd
CY2022	ree	Noncash Reclassification Of Warrant Liability NoncashReclassificationOfWarrantLiability	3104000	usd
CY2021	ree	Noncash Reclassification Of Warrant Liability NoncashReclassificationOfWarrantLiability	0	usd
CY2020	ree	Noncash Reclassification Of Warrant Liability NoncashReclassificationOfWarrantLiability	0	usd
CY2022	ree	Noncash Interest Received NoncashInterestReceived	1905000	usd
CY2021	ree	Noncash Interest Received NoncashInterestReceived	394000	usd
CY2020	ree	Noncash Interest Received NoncashInterestReceived	457000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	590000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56762000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	275772000	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44707000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	162000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	138000	usd
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	800000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	3001000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1005000	usd
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	usd
CY2022Q4	ree	Cash Cash Equivalents Restricted Cash And Cash Equivalents And Short Term Investments CashCashEquivalentsRestrictedCashAndCashEquivalentsAndShortTermInvestments	59925000	usd
CY2021Q4	ree	Cash Cash Equivalents Restricted Cash And Cash Equivalents And Short Term Investments CashCashEquivalentsRestrictedCashAndCashEquivalentsAndShortTermInvestments	276915000	usd
CY2020Q4	ree	Cash Cash Equivalents Restricted Cash And Cash Equivalents And Short Term Investments CashCashEquivalentsRestrictedCashAndCashEquivalentsAndShortTermInvestments	45507000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56762000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	96857000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-107420000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-721928000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates, judgments and assumptions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period and accompanying notes. Actual results could differ from those estimates. The Company’s management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made.</span></div>
CY2022	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	usd
CY2020	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	usd
CY2021	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	usd
CY2021	us-gaap	Severance Costs1 SeveranceCosts1	842000	usd
CY2020	us-gaap	Severance Costs1 SeveranceCosts1	386000	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	30000000	shares
CY2021Q3	ree	Reverse Recapitalization Gross ReverseRecapitalizationGross	348000000	usd
CY2021Q3	us-gaap	Nontrade Receivables NontradeReceivables	46395000	usd
CY2021Q3	us-gaap	Nontrade Receivables NontradeReceivables	38340000	gbp
CY2022	ree	Defined Contribution Plan Maximum Monthly Contributions Per Employee Percent DefinedContributionPlanMaximumMonthlyContributionsPerEmployeePercent	0.0833
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	1217000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of credit risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents restricted cash, and short-term investments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s cash, cash equivalents, restricted cash, and short-term investments are invested in high-quality banks in Israel and the United States. In addition, the Company’s short-term investments are in securities that have investment grade credit ratings. Generally, these securities may be redeemed upon demand and, therefore, bear low risk.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(cont.)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no significant off-balance-sheet concentrations of credit risk such as, foreign exchange contracts and option contracts.</span></div>
CY2022	us-gaap	Advertising Expense AdvertisingExpense	614000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	1000000	usd
CY2020	us-gaap	Advertising Expense AdvertisingExpense	291000	usd
CY2021Q3	ree	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	63000000	usd
CY2021Q3	ree	Reverse Recapitalization Warrants And Rights Outstanding Transaction Costs ReverseRecapitalizationWarrantsAndRightsOutstandingTransactionCosts	2887000	usd
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	26.7017
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	90692220	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	69443231	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	70721964	shares
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1726000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	856000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	943000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	943000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	943000	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	943000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	943000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	943000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	943000	usd
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	943000	usd
CY2022Q4	ree	Lessee Operating Lease Liability To Be Paid Year Five And Thereafter LesseeOperatingLeaseLiabilityToBePaidYearFiveAndThereafter	13384000	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	96857000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	0	usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	219000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	96638000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	28107000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6736000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	21371000	usd
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	870000	usd
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	286000	usd
CY2022Q4	ree	Prepayments To Government Authorities PrepaymentsToGovernmentAuthorities	2302000	usd
CY2021Q4	ree	Prepayments To Government Authorities PrepaymentsToGovernmentAuthorities	897000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5008000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	5151000	usd
CY2022Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	4150000	usd
CY2021Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	5734000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	434000	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	380000	usd
CY2022Q4	ree	Prepaid Expense And Other Accounts Receivable Current PrepaidExpenseAndOtherAccountsReceivableCurrent	11894000	usd
CY2021Q4	ree	Prepaid Expense And Other Accounts Receivable Current PrepaidExpenseAndOtherAccountsReceivableCurrent	12162000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	4163000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	165000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	120000	usd
CY2022	us-gaap	Lease Cost LeaseCost	4448000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	5946000	usd
CY2022Q4	ree	Operating Lease Right Of Use Asset And Lease Liability OperatingLeaseRightOfUseAssetAndLeaseLiability	8857000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	16636000	usd
CY2022	ree	Operating Lease Right Of Use Asset Adjustments OperatingLeaseRightOfUseAssetAdjustments	3796000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y3M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0565
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4260000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3603000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3579000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3281000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18504000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3240000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1565000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	565000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	16939000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2675000	usd
CY2022	us-gaap	Depreciation Depreciation	1683000	usd
CY2021	us-gaap	Depreciation Depreciation	484000	usd
CY2020	us-gaap	Depreciation Depreciation	166000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5190000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8262000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	793000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	600000	usd
CY2022Q4	ree	Accrued Engineering Costs Nonrecurring Current AccruedEngineeringCostsNonrecurringCurrent	572000	usd
CY2021Q4	ree	Accrued Engineering Costs Nonrecurring Current AccruedEngineeringCostsNonrecurringCurrent	4800000	usd
CY2022Q4	ree	Government Authorities Related Liabilities Current GovernmentAuthoritiesRelatedLiabilitiesCurrent	2624000	usd
CY2021Q4	ree	Government Authorities Related Liabilities Current GovernmentAuthoritiesRelatedLiabilitiesCurrent	648000	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1939000	usd
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1708000	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	11118000	usd
CY2021Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	16018000	usd
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022	ree	Number Of Classes Of Common Stock NumberOfClassesOfCommonStock	2	class
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	30000000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	300000	usd
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	2569000	usd
CY2022Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	0	usd
CY2022Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	0	usd
CY2022Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	0	usd
CY2022Q4	ree	Purchase Obligation To Be Paid Year Five And Thereafter PurchaseObligationToBePaidYearFiveAndThereafter	0	usd
CY2022Q4	us-gaap	Purchase Obligation PurchaseObligation	2569000	usd
CY2022Q4	ree	Guaranty Liabilities Current GuarantyLiabilitiesCurrent	162000	usd
CY2022Q4	ree	Guaranty Liabilities Noncurrent GuarantyLiabilitiesNoncurrent	3001000	usd
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	141461817	shares
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	26.7017
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1083417110	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	327477544	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	327477544	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1083417110	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	317679746	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	317679746	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	26892000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	448077000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52763000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	6387000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	113287066	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.20
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y3M10D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	605788000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	361386	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	6361615	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.38
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1799149	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.07
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	105487688	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.19
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	20646000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	101146134	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.18
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y3M3D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	20855000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	23370000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y10M24D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.89
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.76
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.75
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	105487688	shares
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y3M18D
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.19
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	101146134	shares
CY2022	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P7Y3M3D
CY2022Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.18
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	9490000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	173000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-109088000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-498242000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3416000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-5807000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-105672000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-504049000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	35682000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	22723000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	96553000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	98396000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	13379000	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	5586000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	414000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	366000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2679000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2022Q4	ree	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	5227000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	153934000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	127071000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	144444000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	126898000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9490000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	173000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3103000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	173000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	126898000	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9409000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	17546000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	117489000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	144444000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	126898000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1748000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1281000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1748000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1281000	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	136000	usd
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	usd
CY2022	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	1612000	usd
CY2021	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	1281000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1748000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1281000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	856000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	405000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1230000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	856000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	45000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1726000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	856000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	142235000	usd
CY2021Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	15562500	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	15562500	shares
CY2021Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	15562500	shares
CY2022Q3	ree	Class Of Warrant Or Right Exchanged ClassOfWarrantOrRightExchanged	13033350	shares
CY2022Q3	ree	Class Of Warrant Or Right Exchange Ratio ClassOfWarrantOrRightExchangeRatio	0.20
CY2022Q3	ree	Class Of Warrant Or Right Exchange Ratio ClassOfWarrantOrRightExchangeRatio	0.18
CY2022Q3	ree	Class Of Warrant Or Right Exchanged ClassOfWarrantOrRightExchanged	2529100	shares
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3104000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	10670000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-9512000	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	459000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	usd
CY2022	ree	Interest Income Expense And Bank Fees Nonoperating Net InterestIncomeExpenseAndBankFeesNonoperatingNet	2785000	usd
CY2021	ree	Interest Income Expense And Bank Fees Nonoperating Net InterestIncomeExpenseAndBankFeesNonoperatingNet	573000	usd
CY2020	ree	Interest Income Expense And Bank Fees Nonoperating Net InterestIncomeExpenseAndBankFeesNonoperatingNet	409000	usd
CY2022	us-gaap	Translation Adjustment Functional To Reporting Currency Increase Decrease Gross Of Tax TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax	1586000	usd
CY2021	us-gaap	Translation Adjustment Functional To Reporting Currency Increase Decrease Gross Of Tax TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax	-147000	usd
CY2020	us-gaap	Translation Adjustment Functional To Reporting Currency Increase Decrease Gross Of Tax TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax	-27000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4371000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	423000	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	385000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-107420000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-505330000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-67713000	usd
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	388000	usd
CY2022Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	0	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	37000	usd
CY2022Q4	us-gaap	Due To Employees Current And Noncurrent DueToEmployeesCurrentAndNoncurrent	64000	usd
CY2021Q4	us-gaap	Due To Employees Current And Noncurrent DueToEmployeesCurrentAndNoncurrent	49000	usd

Files In Submission

Name	View Source	Status
0001843588-23-000010-index-headers.html	Edgar Link	pending
0001843588-23-000010-index.html	Edgar Link	pending
0001843588-23-000010.txt	Edgar Link	pending
0001843588-23-000010-xbrl.zip	Edgar Link	pending
ex121certificateofchiefexe.htm	Edgar Link	pending
ex122certificateofchieffin.htm	Edgar Link	pending
ex131certificateofchiefexe.htm	Edgar Link	pending
ex132certificateofchieffin.htm	Edgar Link	pending
ex151consentofindependentr.htm	Edgar Link	pending
ex25descriptionofsecurities.htm	Edgar Link	pending
ex46compensationpolicy.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
ree-20221231.htm	Edgar Link	pending
ree-20221231.xsd	Edgar Link	pending
ree-20221231_g1.jpg	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ree-20221231_cal.xml	Edgar Link	unprocessable
ree-20221231_def.xml	Edgar Link	unprocessable
ree-20221231_lab.xml	Edgar Link	unprocessable
ree-20221231_pre.xml	Edgar Link	unprocessable
ree-20221231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$REE
REE Automotive Ltd. Stock $ree

2022 Q4 Form 20-F Financial Statement

#000184358823000010 Filed on March 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REE REE Automotive Ltd. Stock $ree

2022 Q4 Form 20-F Financial Statement

#000184358823000010 Filed on March 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REE
REE Automotive Ltd. Stock $ree